Effect of a Dominant Inhibitory Ha-ras Mutation on Mitogenic Signal Transduction in NIH 3T3 Cells

Literature Cited

• Beckner, S. K., S. Hattori, and T. Y. Shih. 1985. The ras oncogene product p21 is not a regulatory component of adenylate cyclase. Nature (London) 317:71-72.
   PubMed Web of Science ®Google Scholar
• Blair, D. G., W. L. McClements, M. K. Oskarsson, P. J. Fischinger, and G. F. Vande Wounde. 1980. Biological activity of cloned Moloney sarcoma virus DNA. Terminally redundant sequences may enhance transformation efficiency. Proc. Natl. Acad. Sci. USA 77:3504-3508.
   PubMedGoogle Scholar
• Carney, W. P., P. J. Hamer, J. LaVecchio, S. Ng, D. Petit, T. G. Pullano, and K. L. Trimpe. 1989. Monoclonal antibodies for detection of normal and oncogenic ras p21, p. 53-62. In R. S. Metzgar and M. S. Mitchell (ed.), Human tumor antigens and specific tumor therapy. Alan R. Liss, Inc., New York.
   Google Scholar
• Copeland, N. G., and G. M. Cooper. 1979. Transfection by exogenous and endogenous murine retrovirus DNAs. Cell 16:347-356.
   PubMed Web of Science ®Google Scholar
• Feig, L. A., and G. M. Cooper. 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235-3243.
   PubMed Web of Science ®Google Scholar
• Feramisco, J. R., M. Gross, T. Kamata, M. Rosenberg, and R. W. Sweet. 1984. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38:109-117.
   PubMed Web of Science ®Google Scholar
• Fleischman, L. F., S. B. Chahwala, and L. Cantley. 1986. ras-Transformed cells: altered levels of phosphatidylinositol 4,5-bisphosphate and catabolites. Science 232:407-410.
   Google Scholar
• Fujii, M., D. Shalloway, and I. M. Verma. 1989. Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos. Mol. Cell. Biol. 9:2493-2499.
   PubMed Web of Science ®Google Scholar
• Fukumoto, Y., K. Kaibuchi, N. Oku, Y. Hori, and Y. Takai. 1990. Activation of the c-fos serum-response element by the activated c-Ha-ras protein in a manner independent of protein kinase C and cAMP-dependent protein kinase. J. Biol. Chem. 265:774-780.
   PubMedGoogle Scholar
• Furth, M. E., L. J. Davis, B. Fleurdelys, and E. M. Scolnick. 1982. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J. Virol. 43:294-304.
   PubMed Web of Science ®Google Scholar
• Gauthier-Rouviere, C., A. Fernandez, and N. J. C. Lamb. 1990. ras-Induced c-fos expression and proliferation in living rat fibroblasts involves C-kinase activation and the serum response element pathway. EMBO J. 9:171-180.
   PubMedGoogle Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
   PubMed Web of Science ®Google Scholar
• Jamal, S., and E. Ziff. 1990. Transactivation of c-fos and β-actin genes by raf as a step in early response to transmembrane signals. Nature (London) 344:463-466.
   PubMed Web of Science ®Google Scholar
• Lacal, J. C., P. De La Pena, J. Moscat, P. Garcia-Barreno, P. S. Anderson, and S. A. Aaronson. 1987. Rapid stimulation of diacylglycerol production in Xenopus oocytes by microinjection of H-ras p21. Science 238:533-536.
   PubMed Web of Science ®Google Scholar
• Lacal, J. C., T. P. Fleming, B. S. Warren, P. M. Blumberg, and S. A. Aaronson. 1987. Involvement of functional protein kinase C in the mitogenic response to the H-ras oncogene product. Mol. Cell. Biol. 7:4146-4149.
   PubMed Web of Science ®Google Scholar
• Lacal, J. C., J. Moscat, and S. A. Aaronson. 1987. Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature (London) 330:269-272.
   PubMed Web of Science ®Google Scholar
• Lloyd, A. C., H. F. Paterson, J. D. H. Morris, A. Hall, and C. J. Marshall. 1989. p21H-ras-induced morphological transformation and increases in c-myc expression are independent of functional protein kinase C. EMBO J. 8:1099-1104.
   PubMedGoogle Scholar
• Morris, J. D. H., B. Price, A. C. Lloyd, A. J. Self, C. J. Marshall, and A. Hall. 1989. Scrape-loading of Swiss 3T3 cells with rasprotein rapidly activates protein kinase C in the absence of phosphoinositide hydrolysis. Oncogene 4:27-31.
   PubMed Web of Science ®Google Scholar
• Mulcahy, L. S., M. R. Smith, and D. W. Stacey. 1985. Requirement for rasproto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature (London) 313:241-243.
   PubMed Web of Science ®Google Scholar
• Pan, B.-T., and G. M. Cooper. 1990. Role of phosphatidylinositol metabolism in ras-induced Xenopus oocyte maturation. Mol. Cell. Biol. 10:923-929.
   PubMedGoogle Scholar
• Powers, S., K. O’Neill, and M. Wigler. 1989. Dominant yeast and mammalian RASmutants that interfere with the CDC25- dependent activation of wild-type RASin Saccharomyces cerevisiae. Mol. Cell. Biol. 9:390-395.
   PubMed Web of Science ®Google Scholar
• Preiss, J., C. R. Loumis, W. R. Bishop, R. Stein, J. E. Niedel, and R. M. Bell. 1986. Quantitative measurement of sn-12- diacylglycerols present in platelets, hepatocytes, and ras-and sis-transformed normal rat kidney cells. J. Biol. Chem. 261:8597-8600.
   PubMed Web of Science ®Google Scholar
• Sassone-Corsi, P., J. C. Sisson, and I. M. Verma. 1988. Transcriptional autoregulation of the proto-oncogene fos. Nature (London) 334:314-319.
   PubMed Web of Science ®Google Scholar
• Shalloway, D., A. D. Zelenetz, and G. M. Cooper. 1981. Molecular cloning and characterization of the chicken gene homologous to the transforming gene of Rous sarcoma virus. Cell 24:531-541.
   PubMedGoogle Scholar
• Smith, M. R., S. J. DeGudicibus, and D. W. Stacey. 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature (London) 320:540-543.
   PubMed Web of Science ®Google Scholar
• Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-341.
   PubMedGoogle Scholar
• Stacey, D. W., and H. F. Kung. 1984. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature (London) 310:508-511.
   PubMed Web of Science ®Google Scholar
• Stacey, D. W., T. Watson, H. F. Kung, and T. Curran. 1987. Microinjection of transforming ras protein induces c-fos expression. Mol. Cell. Biol. 7:523-527.
   PubMedGoogle Scholar
• Stanton, V. P., Jr., D. W. Nichols, A. Laudano, and G. M. Cooper. 1989. Definition of the human raf amino-terminal regulatory region by deletion mutagenesis. Mol. Cell. Biol. 9:639-647.
   PubMed Web of Science ®Google Scholar
• Szeberenyi, J., H. Cai, and G. M. Cooper. 1990. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 10:5324-5332.
   PubMedGoogle Scholar
• Toda, T., I. Uno, T. Ishikawa, S. Powers, T. Kataoka, D. Broek, S. Cameron, J. Broach, K. Matsumoto, and M. Wigler. 1985. In yeast, ras proteins are controlling elements of adenylate cyclase. Cell 40:27-36.
   PubMed Web of Science ®Google Scholar
• Wakelam, M. J. O., S. A. Davies, M. D. Houslay, I. McKay, C. J. Marshall, and A. Hall. 1986. Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production. Nature (London) 323:173-176.
   PubMed Web of Science ®Google Scholar
• Wasylyk, C., J. L. Imler, and B. Wasylyk. 1988. Transforming but not immortalizing oncogenes activate the transcription factor PEAl. EMBO J. 7:2475-2483.
   PubMedGoogle Scholar
• Wasylyk, C., B. Wasylyk, G. Heidecker, M. Huleihel, and U. R. Rapp. 1989. Expression of raf oncogenes activates the PEAl transcription factor motif. Mol. Cell. Biol. 9:2247-2250.
   PubMedGoogle Scholar
• Wolfes, H., K. Kogawa, C. F. Millette, and G. M. Cooper. 1989. Specific expression of nuclear proto-oncogenes before entry into meiotic prophase of spermatogenesis. Science 245:740-743.
   PubMedGoogle Scholar
• Wolfman, A., and I. G. Macara. 1987. Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras- transformed fibroblasts. Nature (London) 325:359-361.
   PubMed Web of Science ®Google Scholar
• Yu, C.-L., M.-H. Tsai, and D. W. Stacey. 1988. Cellular ras activity and phospholipid metabolism. Cell 52:63-71.
   PubMedGoogle Scholar
• Zaret, K. S., and K. R. Yamamoto. 1984. Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element. Cell 38:29-38.
   PubMed Web of Science ®Google Scholar